Partex and Sanofi Partner for AI-Enhanced Dossier Improvement

Partex Group, an AI-driven drug discovery company, today announces a collaboration with global pharmaceutical company Sanofi, aimed at using Partex’s AI technology to enhance the value of Sanofi's out-licensing portfolio.

Partex and Sanofi are expanding their collaboration, leveraging Partex’s AI subsidiary, Innoplexus, to identify new uses for Sanofi’s out-licensing portfolio. The partnership aims to discover new opportunities through detailed analysis and lab validation studies. Innoplexus will play a key role in examining and enhancing various out-licensing asset candidates across different therapeutic areas, with the ultimate goal of repurposing these assets to meet patient needs.

Gunjan Bhardwaj, CEO of Partex, commented, “Our collaboration with Sanofi exemplifies our dedication to driving innovation in drug discovery. By harnessing the power of AI, we aspire to unlock the hidden potential within Sanofi's out-licensing portfolio and bring hope to patients suffering from unmet medical needs. This collaboration is a testament to our shared commitment to advancing healthcare through cutting-edge technology.”

The collaboration is already in motion, with the selection of the first three assets for AI predictions, set to be completed in 2024. Partex will receive an upfront cash component at the start of the collaboration and an opportunity to receive additional future financial incentives.

Partex NV and Sanofi establish a partnership for AI-enhanced dossier...
Partex NV and Sanofi establish a partnership for AI-enhanced dossier improvement in out-licensing. © Adobe Stock

Company

Partex N.V.

Frankfurter Straße 27
65760 Eschborn
Germany

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.